AGP Picks
View all

The latest health and wellness news from Maryland

Provided by AGP

Got News to Share?

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

Press releases published on May 22, 2026

China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis
STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026
Hanmi Pharmaceutical se asocia con Organon para exportar terapias combinadas al Sudeste Asiático
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático
ANGEL Introduces X2 Water Filter System with Advanced Tankless 7-Stage Filtration and 99% PFAS Reduction
OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute
OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer
NervGen Announces Pricing of US$60.0 Million Public Offering of Securities
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
FemiCore Claims Evaluated: Investigating the Ingredients for Bladder Support - Femi Core Consumer Complaints Exposed
Most Effective Magnesium Pain Cream Researched: Real Magnesium Niacinamide Relief for Peak Health & Nerve Pain Recovery
Liminatus Pharma Announces Nasdaq Delisting Notification
TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

Share us

on your social networks:

Sign up for:

Maryland Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.